Orap

Active Ingredient(s): Pimozide
FDA Approved: * July 31, 1984
Pharm Company: * TEVA
Category: Antipsychotic

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the Q... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Orap ORAP;1
Orap 1 mg Oral Tablet
NDC: 57844-151
Labeler:
Teva Select Brands
Orap LEMMON;ORAP;2
Orap 2 mg Oral Tablet
NDC: 57844-187
Labeler:
Teva Select Brands
Orap 2 mg Oral Tablet
NDC: 57844-198
Labeler:
Teva Select Brands

Popular Topics

Orap Concerns

My 15 year old son will be starting Orap for his severe breathing tics for the first time. I am terrified of this drug b...

1 REPLY
side effects of orapred in children under 5

I have been told the long term side effects are not good. My son has been prescribed this by his doctor for asthma relas...

1 REPLY